pVHL function is essential for endothelial extracellular matrix deposition

被引:70
作者
Tang, N
Mack, F
Haase, VH
Simon, MC
Johnson, RS
机构
[1] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Mol Pathol Grad Program, La Jolla, CA 92093 USA
[3] Univ Penn, Abramson Family Canc Res Inst, Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Renal Electrolyte & Hypertens Div, Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1128/MCB.26.7.2519-2530.2006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor von Hippel-Lindau protein (pVHL) is critical for cellular molecular oxygen sensing, acting to target degradation of the hypoxia-inducible factor alpha transcription factor subunits under normoxic conditions. We have found that independent of its function in regulating hypoxic response, the VHL gene plays a critical role in embryonic endotheliurn development through regulation of vascular extracellular matrix assembly. We created mice lacking the VHL gene in endothelial cells; these conditional null mice died at the same stage as homozygous VHL-null mice, with similar vascular developmental defects. These included defective vasculogenesis in the placental labyrinth, a collapsed endocardium, and impaired vessel network patterning. The defects in embryonic vascularization were correlated with a diminished vascular fibronectin deposition in vivo and defective endothelial extracellular fibronectin assembly in vitro. We found that the impaired migration and adhesion of VHL-null endothelial cells can be partially rescued by the addition of back exogenous fibronectin, which indicates that pVHL regulation of fibronectin deposition plays an important functional role in vascular patterning and maintenance of vascular integrity.
引用
收藏
页码:2519 / 2530
页数:12
相关论文
共 53 条
[1]  
Abbott BD, 2000, DEV DYNAM, V219, P526, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1080>3.0.CO
[2]  
2-N
[3]   Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses [J].
Adelman, DM ;
Gertsenstein, M ;
Nagy, A ;
Simon, MC ;
Maltepe, E .
GENES & DEVELOPMENT, 2000, 14 (24) :3191-3203
[4]   Tracheal development and the von Hippel-Lindau tumor suppressor homolog in Drosophila [J].
Adryan, B ;
Decker, HJH ;
Papas, TS ;
Hsu, T .
ONCOGENE, 2000, 19 (24) :2803-2811
[5]   Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation [J].
Alexander, JS ;
Elrod, JW .
JOURNAL OF ANATOMY, 2002, 200 (06) :561-574
[6]   Genetic analysis of pathways regulated by the von Hippel-Lindau tumor suppressor in Caenorhabditis elegans [J].
Bishop, T ;
Lau, KW ;
Epstein, ACR ;
Kim, SK ;
Min, J ;
O'Rourke, D ;
Pugh, CW ;
Gleadle, JM ;
Taylor, MS ;
Hodgkin, J ;
Ratcliffe, PJ .
PLOS BIOLOGY, 2004, 2 (10) :1549-1560
[7]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[8]   An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association [J].
Cohen, HT ;
Zhou, M ;
Welsh, AM ;
Zarghamee, S ;
Scholz, H ;
Mukhopadhyay, D ;
Kishida, T ;
Zbar, B ;
Knebelmann, B ;
Sukhatme, VP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 266 (01) :43-50
[9]   Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter [J].
Coulet, F ;
Nadaud, S ;
Agrapart, M ;
Soubrier, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) :46230-46240
[10]  
Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO